Skip to content
lifestyle.militaryparenting.org
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Tech
Travel
Author:
BERRY & COMPANY PUBLIC RELATIONS
Solu Therapeutics Granted FDA Fast Track Designation for STX-0712 for Treatment of Chronic Myelomonocytic Leukemia
May 27, 2026
GRIN Therapeutics’ Pivotal Phase 3 Beeline Study Initiated in Europe
May 4, 2026